Señales en vivo de DCPH | Maximiza tus Ganancias con Getagraph.com

VENDER 114926 min ago

@ $14.50

Emitido: 13 feb 2024 @ 15:32

Retorno: 75.03%

Señal anterior: feb 13 - 15:13

Señal anterior: Comprar

Retorno: 1.40 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:58):

Stats
Volumen de hoy	810 875
Volumen promedio	1.50M
Capitalización de mercado	2.09B
EPS	$0 ( 2024-05-01 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-11.08
ATR14	$0.00800 (0.03%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-22	Brightstar Associates Llc	Buy	48 136	Common Stock
2024-04-22	Brightstar Associates Llc	Sell	48 136	Warrants (right to buy)
2024-02-15	Sherman Matthew L	Buy	17 275	Common Stock
2024-02-16	Sherman Matthew L	Sell	2 615	Common Stock
2024-02-15	Sherman Matthew L	Buy	69 100	Stock Option (Right to Buy)

INSIDER POWER
31.23
Last 99 transactions
Buy: 7 012 970 \| Sell: 3 558 980

Volumen Correlación

Largo: 0.19 (neutral)

Corto: -0.53 (weak negative)

Signal:(45.725) Neutral

Deciphera Pharmaceuticals Correlación

10 Correlaciones Más Positivas
LWACU	0.932
LWAC	0.93
VOSOU	0.922
DFPH	0.91
GSMG	0.91
AGBA	0.88
PPGHU	0.876
MRAC	0.874
BNIXU	0.869
HOTH	0.83

10 Correlaciones Más Negativas
ESAC	-0.928
CTAC	-0.915
MCAE	-0.909
BCYP	-0.895
KURI	-0.857
MACQU	-0.856
MAAC	-0.851
BCYPU	-0.849
CMLT	-0.842
PRSR	-0.835

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Deciphera Pharmaceuticals Correlación - Moneda/Commodity

0.75
( moderate )

0.56
( weak )

0.00
( neutral )

0.35
( neutral )

0.40
( neutral )

Deciphera Pharmaceuticals Finanzas

Annual	2023
Ingresos:	$163.36M
Beneficio Bruto:	$159.62M (97.72 %)
EPS:	$-2.29

FY	2023
Ingresos:	$163.36M
Beneficio Bruto:	$159.62M (97.72 %)
EPS:	$-2.29

FY	2022
Ingresos:	$134.04M
Beneficio Bruto:	$125.27M (93.46 %)
EPS:	$-2.37

FY	2021
Ingresos:	$96.15M
Beneficio Bruto:	$93.22M (96.95 %)
EPS:	$-5.16

Financial Reports:

No articles found.

Deciphera Pharmaceuticals

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.